Bhuvanesh Dave Selected Research

HLA Antigens (Human Leukocyte Antigens)

1/2018

Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bhuvanesh Dave Research Topics

Disease

24	Neoplasms (Cancer) 11/2019 - 10/2005
17	Breast Neoplasms (Breast Cancer) 11/2019 - 10/2005
5	Triple Negative Breast Neoplasms 01/2018 - 09/2014
2	Neoplasm Metastasis (Metastasis) 11/2019 - 06/2014
2	Myeloid Leukemia (Leukemia, Myelocytic) 11/2019 - 06/2014
2	Hypoxia (Hypoxemia) 02/2015 - 06/2014
2	Carcinogenesis 01/2015 - 01/2010
1	Disease Progression 11/2019
1	Melanoma (Melanoma, Malignant) 01/2018
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2016
1	Cardiogenic Shock 02/2015
1	Tics (Tic) 01/2014
1	Obesity 04/2012
1	Residual Neoplasm 01/2012
1	Pathologic Complete Response 01/2011
1	Ductal Carcinoma 01/2010
1	Leiomyoma (Uterine Fibroids) 08/2009
1	Carcinoma (Carcinomatosis) 05/2009
1	Tuberous Sclerosis (Bourneville's Disease) 05/2008
1	Endometrial Neoplasms (Endometrial Cancer) 05/2008
1	Hepatocellular Carcinoma (Hepatoma) 06/2002

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 07/2015 - 01/2010
4	Small Interfering RNA (siRNA)IBA 06/2014 - 03/2011
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2013 - 05/2008
4	TensinsIBA 01/2013 - 05/2008
3	ribosomal protein L39IBA 11/2019 - 06/2014
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2018 - 02/2015
3	Docetaxel (Taxotere)FDA Link 01/2018 - 01/2012
3	TOR Serine-Threonine KinasesIBA 10/2016 - 05/2008
3	ErbB Receptors (EGF Receptor)IBA 07/2015 - 01/2011
3	Pharmaceutical PreparationsIBA 10/2014 - 03/2009
3	IsoflavonesIBA 01/2013 - 10/2005
2	RNA (Ribonucleic Acid)IBA 01/2017 - 02/2013
2	Estrogen ReceptorsIBA 08/2014 - 04/2012
2	Trastuzumab (Herceptin)FDA Link 02/2013 - 01/2011
2	GenisteinIBA 01/2013 - 10/2005
2	Lapatinib (GW572016)FDA Link 03/2011 - 01/2011
2	Phosphotransferases (Kinase)IBA 01/2011 - 06/2002
2	Sirolimus (Rapamycin)FDA Link 08/2009 - 05/2008
1	Cell-Free Nucleic AcidsIBA 11/2019
1	Tumor Biomarkers (Tumor Markers)IBA 11/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	CytokinesIBA 01/2018
1	Arginine (L-Arginine)FDA Link 01/2017
1	EnzymesIBA 01/2017
1	Adenosine DeaminaseIBA 01/2017
1	Acetates (Acetic Acid Esters)FDA Link 01/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2016
1	Protein Kinases (Protein Kinase)IBA 01/2016
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2015
1	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 02/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2015
1	Activating Transcription Factor 3IBA 02/2015
1	Activating Transcription Factor 4IBA 02/2015
1	Nitric Oxide Synthase (NO Synthase)IBA 06/2014
1	XL147IBA 02/2013
1	SurvivinIBA 02/2013
1	Biological ProductsIBA 01/2013
1	Peptides (Polypeptides)IBA 01/2013
1	Levonorgestrel (Plan B)FDA LinkGeneric 04/2012
1	Insulin (Novolin)FDA Link 04/2012
1	HexestrolIBA 04/2012
1	Estrogens (Estrogen)FDA Link 04/2012
1	Estradiol (Delestrogen)FDA LinkGeneric 04/2012
1	Insulin-Like PeptidesIBA 04/2012
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 04/2012
1	Tyrosine Kinase InhibitorsIBA 01/2011
1	human ERBB2 proteinIBA 01/2011
1	Monoclonal AntibodiesIBA 01/2011
1	progesterone receptor AIBA 01/2010
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2010
1	Soybean Proteins (Soy Protein)IBA 01/2010
1	Caseins (Casein)FDA Link 01/2010
1	Protein Isoforms (Isoforms)IBA 01/2010
1	Messenger RNA (mRNA)IBA 08/2009
1	MTOR InhibitorsIBA 05/2008
1	WortmanninIBA 05/2008
1	Tuberous Sclerosis Complex 2 ProteinIBA 05/2008
1	AMP-Activated Protein KinasesIBA 05/2008
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2008
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 05/2008
1	Protein Kinase CIBA 06/2002
1	calphostin CIBA 06/2002

Therapy/Procedure

9	Therapeutics 11/2019 - 01/2012
3	Drug Therapy (Chemotherapy) 09/2014 - 03/2009
1	Immunotherapy 01/2018
1	Intravenous Injections 01/2018
1	Radiotherapy 01/2015
1	Hysterectomy 08/2009